Eli Lilly and Company


Baxter drug fails to slow Alzheimer’s in big study

DEERFIELD, Ill. (AP) — Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to […]



Lilly drug chosen for Alzheimer’s prevention study

(AP) – Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study aiming to prevent Alzheimer’s disease in older people at high risk of developing it.


Scientists in drug research lab

Study: Hundreds of rare disease drugs in testing

(AP) — For the nearly 30 million Americans who suffer from a rare disease, there’s heartening news: Drugmakers are now researching uncommon disorders that often kill prematurely because of few or no treatment options.



New Alzheimer’s drug studies offer patients hope

TRENTON, N.J. (AP) – For Alzheimer’s patients desperate for an effective treatment, several new studies starting up offer hope.

After dozens of promising experimental drugs failed, scientists think they’re now on the right track.



Get every new post delivered to your Inbox.

Join 28,182 other followers